dongmei shi | Immunology | Global Impact in Research Award

Posted on by sciencefather

Dr. Dongmei shi | Immunology | Global Impact in Research Award

Dr. Dongmei shi, Jining NO.1 peoples’ hospital, China.

Dr. Dongmei Shi πŸ§ͺ is a Professor of Dermatology at Jining No.1 People’s Hospital, specializing in medical mycology 🦠 and infection immunology πŸ›‘οΈ. She has discovered new fungal species, revealed immune evasion pathways, and developed innovative diagnostic tools πŸ”¬. A leader in clinical and translational research, Dr. Shi has led several nationally funded projects πŸ‡¨πŸ‡³ and serves on prestigious medical committees πŸ‘©β€βš•οΈ. Her work significantly advances skin infection treatment and global dermatological science 🌍.

🌟 Professional Profile

Scopus profile

πŸŽ“ Early Academic Pursuits

Dr. Dongmei Shi earned her doctoral degree in Dermatology and Venereology from the esteemed Fourth Military Medical University. Her academic foundation was built on rigorous training and a commitment to deepening her understanding of skin disorders and infections. From the outset, she demonstrated a keen interest in medical mycology and infection immunology, which laid the groundwork for her future innovations and research contributions.

πŸ’Ό Professional Endeavors

Currently serving as a Professor in the Department of Dermatology and the Medical Mycology Laboratory at Jining NO.1 People’s Hospital, Dr. Shi has built an impressive career. With years of clinical experience, she excels in diagnosing and treating a wide range of skin diseases. Her work merges clinical acumen with scientific inquiry, making her a pivotal figure in integrating patient care with research-driven solutions.

πŸ”¬ Contributions and Research Focus On ImmunologyΒ 

Dr. Shi’s research spans the taxonomy of medical fungi, the pathogenicity of fungal infections, and the immune responses triggered by skin pathogens. She has discovered novel fungal species and immune evasion pathways that pave the way for targeted antifungal drug development. Her innovation extends to clinical technologies, including a rapid fungal detection kit and novel treatment strategies using phototherapy and biologics, improving diagnostic precision and therapeutic outcomes.

🌍 Impact and Influence

Her findings have redefined aspects of fungal taxonomy and infection immunology, directly impacting clinical practices and theoretical knowledge in dermatology. Through her projects funded by the National Natural Science Foundation of China and provincial bodies, she has created platforms for translational research, driving both academic progress and patient care. Her rapid diagnostic tools and immunotherapy strategies are increasingly recognized in the medical community.

πŸ† Awards and Honors

Dr. Shi’s leadership and scholarly impact have earned her positions in multiple prestigious organizations. She is a Council Member of the Asia-Pacific Medical Mycology Society, Editorial Board Member of the Chinese Journal of Mycology, and Executive Committee Member in various national dermatological and medical mycology societies. These roles recognize her excellence and her influential voice in shaping dermatological science.

πŸ“ŠAcademic Citations

Dr. Shi has published numerous high-quality papers in top-tier dermatological and mycological journals, significantly contributing to the body of literature in her field. Her work on Candidalysin pathways, dendritic cell modulation, and immune response mechanics is frequently cited by peers, reflecting the global relevance and scientific rigor of her research.

πŸš€ Legacy and Future Contributions

Dr. Dongmei Shi stands as a beacon of innovation in dermatology, bridging research, clinical practice, and technology. Her future work aims to further unravel the complex interplay between fungal pathogens and immune responses, explore personalized immunotherapy, and advance standardization in dermatological diagnostics. As she continues to lead groundbreaking studies and mentor emerging scholars, her legacy is set to inspire generations of medical professionals. 🌱

πŸ“šPublications Top Notes

1️⃣ Photodynamic therapy combined with palliative resection and secondary healing for periocular basal cell carcinoma with inadequate surgical margins

πŸ‘©β€βš•οΈ Authors: X. Wang, T. Zhang, T. Li, Y. Song, D. Shi, Dongmei
πŸ—“οΈ Journal: Photodiagnosis and Photodynamic Therapy
πŸ“… Year: 2025
πŸ”¬ Type: Article

2️⃣ Successful management of recurrent cutaneous granulomas caused by Candida albicans using aminolevulinic acid photodynamic therapy post-surgery: A case report

πŸ‘©β€βš•οΈ Authors: L. Wang, Y. Feng, S. Wang, Z. Yang, D. Shi, Dongmei
πŸ—“οΈ Journal: Photodiagnosis and Photodynamic Therapy
πŸ“… Year: 2025
πŸ“ Type: Case Report

3️⃣ Immunoglobulin E, the potential accelerator of comorbid psoriasis and atherosclerosis

πŸ‘©β€βš•οΈ Authors: Y. Wang, D. Li, Z. Yan, D. Shi, Dongmei
πŸ”’ Citations: 1
πŸ§ͺ Type: Review

4️⃣ Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review)

πŸ‘©β€βš•οΈ Authors: J. Zhang, Y. Feng, D. Li, D. Shi, Dongmei
🧬 Type: Review

5️⃣ Decoding the enigmatic role of T-cadherin in tumor angiogenesis

πŸ‘©β€βš•οΈ Authors: H. Xiong, D. Shi, Dongmei
🧠 Type: Review

6️⃣ Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China

πŸ‘©β€βš•οΈ Authors: P. Cui, D. Li, L. Shi, R. Li, D. Shi, Dongmei
πŸ—“οΈ Journal: Scientific Reports
πŸ“… Year: 2024
πŸ”’ Citations: 2
πŸ“Š Type: Article

7️⃣ Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates

πŸ‘©β€βš•οΈ Authors: D. Shi, Dongmei, Z. Yang, W. Liao, S. de Hoog, S. Deng
πŸ—“οΈ Journal: IMA Fungus
πŸ“… Year: 2024
πŸ”’ Citations: 2
🧫 Type: Article

8️⃣ Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition)

πŸ‘©β€βš•οΈ Authors: G. Liang, X. Li, R. Li, X. Kong, W. Liu
πŸ—“οΈ Journal: Mycoses
πŸ“… Year: 2024
πŸ“œ Type: Consensus Statement

Eun Sook Hwang | Immunology | Best Researcher Award

Posted on by sciencefather

Prof. Eun Sook Hwang | Immunology | Best Researcher AwardΒ 

Prof. Eun Sook Hwang, Ewha Womans University, South Korea.

Professor. Eun Sook Hwang is a distinguished researcher at Ewha Womans University, specializing in immunology, cell biology, and pharmacology. With 12 national research projects, 105 SCI(E) publications, and an H-index of 35, her work has significantly advanced immune regulation, inflammation, and tissue regeneration studies. She has authored two books, collaborated globally with leading scientists, and serves as an editor for Frontiers in Bioscience-Landmark and Diseases & Research. As Chairperson of the Academic Committee of the Korean Pharmaceutical Society and President of the Woman Bioscience Forum, she is dedicated to mentoring young scientists and driving impactful biomedical research.

Professional Profile:

🌟Suitability for Best Researcher Award

Professor. Eun Sook Hwang is a distinguished researcher with a prolific academic and scientific record in immunology, pharmacology, and regenerative medicine. Her extensive contributions include 105 SCI-indexed publications, 12 nationally funded research projects, and significant industry collaborations. With a citation index of 4,867 and an H-index of 35, her impact on the field is evident. She has also contributed through editorial roles, leadership positions, and global collaborations. Her groundbreaking work in immune regulation, T-cell differentiation, and therapeutic development has propelled advancements in autoimmune disease and cancer research.

Professor. Hwang’s exemplary research output, leadership in scientific communities, and dedication to mentoring future researchers make her a highly suitable candidate for the Best Researcher Award.

πŸŽ“Β Educational Background:

Professor. Eun Sook Hwang holds a distinguished academic background in biosciences, specializing in immunology, cell biology, and pharmacology. She earned her doctoral degree in pharmaceutical sciences, focusing on molecular mechanisms of immune regulation and inflammation. Her academic journey has been marked by rigorous research and a commitment to advancing biomedical knowledge. Through extensive training and specialization, she has developed expertise in transcription factors, T-cell differentiation, and tissue regeneration. Her education has laid a strong foundation for her prolific research career, leading to numerous high-impact publications, global collaborations, and leadership roles in academic and scientific organizations.

πŸ’Ό ProfessionalΒ Experience:

Professor. Eun Sook Hwang has an extensive professional background in immunology, cell biology, and pharmacology, currently serving as a professor at Ewha Womans University. She has led 12 national research projects, contributed to over 105 SCI(E) journal publications, and achieved an H-index of 35. Her expertise extends to consultancy and industry projects, editorial roles in Frontiers in Bioscience-Landmark and Diseases & Research, and authorship of two books. She actively collaborates with global researchers and holds leadership positions, including Chairperson of the Academic Committee of the Korean Pharmaceutical Society and President of the Woman Bioscience Forum, mentoring future scientists.

🌍Research and Innovations: 

Professor. Eun Sook Hwang has made significant contributions to immunology, cell biology, and pharmacology through her extensive research and innovations. She has led 12 national research projects and published 105 SCI(E) journal articles, accumulating 4,867 citations with an H-index of 35. Her studies on immune regulation, T-cell differentiation, and inflammation have paved the way for novel therapies in autoimmune diseases, cancer, and fibrosis. She has authored two books, contributed to three industry projects, and holds editorial roles in prestigious journals. Her global collaborations and research on small molecules and tissue regeneration have advanced drug development and biomedical science.

πŸ’‘Recognition and Impact:

Professor. Eun Sook Hwang has received numerous accolades for her groundbreaking contributions to immunology, cell biology, and pharmacology. Her extensive research, spanning 105 SCI(E) publications and 12 nationally funded projects, has earned global recognition. She holds editorial positions in Frontiers in Bioscience-Landmark and Diseases & Research and has collaborated with leading institutions such as NIH and NYU Langone. As Chairperson of the Academic Committee of the Korean Pharmaceutical Society and President of the Woman Bioscience Forum, she has been honored for her leadership and mentorship. Her dedication to scientific excellence continues to shape biomedical research and innovation worldwide.

Conclusion:

Professor. Hwang’s exemplary research output, leadership in scientific communities, and dedication to mentoring future researchers make her a highly suitable candidate for the Best Researcher Award. Her pioneering studies have significantly influenced biomedical research, fostering innovation and scientific progress on a global scale

 

πŸ“šPublication Top Notes

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

Citation: 1190

Year: 2005

πŸ“‘πŸ§¬

T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3

Citation: 759

Year: 2005

πŸ”¬πŸ§¬

T-bet represses TH17 differentiation by preventing Runx1-mediated activation of the gene encoding RORΞ³t

Citation: 520

Year: 2011

πŸ§¬πŸ“š

TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids

Citation: 236

Year: 2004

πŸŒΏπŸ’¨

Shear stress induced by an interstitial level of slow flow increases the osteogenic differentiation of mesenchymal stem cells through TAZ activation

Citation: 222

Year: 2014

βš™οΈπŸ¦΄

IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508

Citation: 192

Year: 2005

🧬🦠

T-bet-dependent expression of osteopontin contributes to T cell polarization

Citation: 179

Year: 2005

πŸ”¬πŸ¦ 

Extracellular matrix stiffness regulates osteogenic differentiation through MAPK activation

Citation: 133

Year: 2015

πŸ§¬βš™οΈ

T-bet polymorphisms are associated with asthma and airway hyperresponsiveness

Citation: 133

Year: 2006

πŸŒΏπŸ’¨

Spontaneous and aging-dependent development of arthritis in NADPH oxidase 2 deficiency through altered differentiation of CD11b+ and Th/Treg cells

Citation: 131

Year: 2011

🧬🦴